Morgan Stanley restated their equal weight rating on shares of Mettler-Toledo International, Inc. (NYSE:MTD) in a report issued on Friday morning. Morgan Stanley currently has a $535.00 target price on the medical instruments supplier’s stock, down from their prior target price of $565.00.

A number of other research analysts also recently commented on MTD. BidaskClub downgraded Mettler-Toledo International from a strong-buy rating to a buy rating in a research report on Tuesday, June 13th. Jefferies Group LLC reiterated a hold rating and set a $550.00 target price on shares of Mettler-Toledo International in a research report on Tuesday, June 20th. Zacks Investment Research downgraded Mettler-Toledo International from a buy rating to a hold rating in a research report on Tuesday, July 11th. Finally, Wells Fargo & Company upgraded Mettler-Toledo International from a market perform rating to an outperform rating in a research report on Wednesday, July 12th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company has a consensus rating of Buy and a consensus target price of $589.33.

Mettler-Toledo International (NYSE MTD) traded up 0.14% on Friday, hitting $645.76. 81,331 shares of the company’s stock traded hands. Mettler-Toledo International has a 12 month low of $395.61 and a 12 month high of $647.97. The stock has a 50 day moving average price of $616.52 and a 200-day moving average price of $570.40. The stock has a market cap of $16.58 billion, a P/E ratio of 39.71 and a beta of 1.11.

Mettler-Toledo International (NYSE:MTD) last posted its earnings results on Thursday, July 27th. The medical instruments supplier reported $3.92 EPS for the quarter, beating analysts’ consensus estimates of $3.89 by $0.03. The firm had revenue of $653.70 million during the quarter, compared to the consensus estimate of $646.68 million. Mettler-Toledo International had a return on equity of 95.28% and a net margin of 16.60%. The company’s quarterly revenue was up 7.5% compared to the same quarter last year. During the same period in the prior year, the company earned $3.22 EPS. Equities analysts predict that Mettler-Toledo International will post $17.33 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Mettler-Toledo International, Inc. (MTD) Receives Equal Weight Rating from Morgan Stanley” was first published by TheOlympiaReport and is the sole property of of TheOlympiaReport. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international trademark & copyright law. The legal version of this piece can be read at https://theolympiareport.com/2017/10/07/mettler-toledo-international-inc-mtd-receives-equal-weight-rating-from-morgan-stanley.html.

In related news, insider Christian Magloth sold 750 shares of the firm’s stock in a transaction on Thursday, August 24th. The stock was sold at an average price of $590.00, for a total value of $442,500.00. Following the completion of the sale, the insider now directly owns 750 shares in the company, valued at $442,500. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Thomas P. Salice sold 890 shares of the firm’s stock in a transaction on Thursday, September 7th. The stock was sold at an average price of $611.00, for a total value of $543,790.00. Following the completion of the sale, the director now owns 62,437 shares of the company’s stock, valued at $38,149,007. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 27,356 shares of company stock valued at $16,150,829. 5.20% of the stock is owned by corporate insiders.

Institutional investors and hedge funds have recently modified their holdings of the stock. First Personal Financial Services lifted its position in Mettler-Toledo International by 2.8% in the second quarter. First Personal Financial Services now owns 186 shares of the medical instruments supplier’s stock worth $109,000 after buying an additional 5 shares during the last quarter. Sun Life Financial INC lifted its position in Mettler-Toledo International by 2,585.7% in the second quarter. Sun Life Financial INC now owns 188 shares of the medical instruments supplier’s stock worth $111,000 after buying an additional 181 shares during the last quarter. Acrospire Investment Management LLC bought a new stake in Mettler-Toledo International in the second quarter worth $118,000. CAPROCK Group Inc. bought a new stake in Mettler-Toledo International in the second quarter worth $205,000. Finally, Personal Capital Advisors Corp bought a new stake in Mettler-Toledo International in the second quarter worth $206,000. Institutional investors own 93.18% of the company’s stock.

About Mettler-Toledo International

Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.

Analyst Recommendations for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.